Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,333 JPY | +1.04% | -0.13% | +7.98% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.48 for the 2024 fiscal year.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.98% | 2.74B | - | ||
-9.73% | 3.79B | D+ | ||
-0.73% | 3.42B | D- | ||
+11.98% | 2.7B | C+ | ||
-9.90% | 1.78B | - | ||
+11.26% | 1.42B | - | - | |
-20.03% | 976M | - | ||
-37.98% | 709M | - | - | |
-0.53% | 456M | - | D+ | |
+5.58% | 407M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 7649 Stock
- Ratings Sugi Holdings Co.,Ltd.